IL86675A - Immunogen containing non- infectious hiv particles and pharmaceutical compositions containing the same - Google Patents

Immunogen containing non- infectious hiv particles and pharmaceutical compositions containing the same

Info

Publication number
IL86675A
IL86675A IL86675A IL8667588A IL86675A IL 86675 A IL86675 A IL 86675A IL 86675 A IL86675 A IL 86675A IL 8667588 A IL8667588 A IL 8667588A IL 86675 A IL86675 A IL 86675A
Authority
IL
Israel
Prior art keywords
immunogen
retrovirus
hiv
infectious
useful
Prior art date
Application number
IL86675A
Other languages
English (en)
Inventor
Jonas Salk
Dennis J Carlo
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Priority to IL10433888A priority Critical patent/IL104338A/en
Priority to IL10434088A priority patent/IL104340A/en
Priority to IL10433788A priority patent/IL104337A/en
Priority to IL10433988A priority patent/IL104339A/en
Priority to IL104338A priority patent/IL104338A0/xx
Priority to IL104337A priority patent/IL104337A0/xx
Priority to IL104339A priority patent/IL104339A0/xx
Priority to IL104340A priority patent/IL104340A0/xx
Publication of IL86675A publication Critical patent/IL86675A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
IL86675A 1987-06-10 1988-06-09 Immunogen containing non- infectious hiv particles and pharmaceutical compositions containing the same IL86675A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IL10433888A IL104338A (en) 1987-06-10 1988-06-09 Immunoglobulin preparation for VIH and a method for its preparation
IL10434088A IL104340A (en) 1987-06-10 1988-06-09 Antidotes against idiotyps that react with anti-PG 021 \ 061 antibodies
IL10433788A IL104337A (en) 1987-06-10 1988-06-09 Antibodies that react with one or more retroviral VIH proteins
IL10433988A IL104339A (en) 1987-06-10 1988-06-09 Method for removing antibodies to PG 061 \ 021 outside the body of an individual infected with VIH
IL104338A IL104338A0 (en) 1987-06-10 1993-01-07 Method of obtaining immunoglobulins,immunoglobulins produced thereby and pharmaceutical compositions containing the same
IL104337A IL104337A0 (en) 1987-06-10 1993-01-07 Antibodies reactive with one or more retroviral proteins and pharmaceutical compositions containing the same
IL104339A IL104339A0 (en) 1987-06-10 1993-01-07 Method for the extracorporeal removal of antibodies
IL104340A IL104340A0 (en) 1987-06-10 1993-01-07 Anti-idiotype antibodies

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6028087A 1987-06-10 1987-06-10
US20075288A 1988-05-31 1988-05-31

Publications (1)

Publication Number Publication Date
IL86675A true IL86675A (en) 1993-04-04

Family

ID=26739775

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86675A IL86675A (en) 1987-06-10 1988-06-09 Immunogen containing non- infectious hiv particles and pharmaceutical compositions containing the same

Country Status (14)

Country Link
EP (3) EP0602761A1 (de)
JP (1) JPH0720880B2 (de)
AT (1) ATE132374T1 (de)
AU (1) AU612383B2 (de)
CA (1) CA1336407C (de)
DE (1) DE3854857T2 (de)
DK (1) DK56389A (de)
FI (1) FI95871C (de)
IL (1) IL86675A (de)
NO (1) NO175846C (de)
OA (1) OA09037A (de)
RU (1) RU2111010C1 (de)
UA (1) UA27716C2 (de)
WO (1) WO1988009670A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI885441L (fi) * 1987-03-23 1988-11-23 Hiver Ltd Nya vaccin.
US5256767A (en) * 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5227159A (en) * 1989-01-31 1993-07-13 Miller Richard A Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
WO1990015133A1 (fr) * 1989-05-30 1990-12-13 Nippon Zeon Co., Ltd. Procede de production de structures de noyau de retrovirus et particules ainsi produites
FR2661834B1 (fr) * 1990-05-09 1995-01-27 Merieux Inst Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus.
AU4685293A (en) * 1992-07-20 1994-02-14 Immune Response Corporation, The Prophylactic and therapeutic control of retroviral infections
DE69515028T2 (de) * 1994-03-22 2000-06-29 The Immune Response Corp., Carlsbad Die hocheffiziente herstellung und isolierung von viruspartikeln
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.
WO2003016337A1 (en) * 2001-08-07 2003-02-27 Medestea Internazionale S.R.L. Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
DK507185A (da) * 1984-11-05 1986-05-06 Du Pont Fremgangsmaade til inaktivering af human tumor leukaemi virus iii
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
DE3588134T2 (de) * 1984-12-24 1997-03-20 Genentech Inc Fusionen von AIDS-verwandten Polypeptiden
ES8706824A1 (es) * 1985-04-08 1987-07-01 Genetic Systems Corp Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia.
FI861626A7 (fi) * 1985-04-19 1986-10-20 Hoffmann La Roche Foervaervat immunbristsyndrom (aids) -relaterat viralt rekombinant hoeljeprotein samt ett testfoerfarande foer aids.
WO1987002892A1 (en) * 1985-11-14 1987-05-21 President And Fellows Of Harvard College T-lymphotrophic virus
EP0250128A3 (de) * 1986-06-18 1988-06-08 American Registry of Pathology Von AIDS-Patienten isoliertes Virus
CA1341277C (en) * 1987-03-16 2001-07-31 Roland Keith Mcgready Anti-paratopic antibody and a method of its manufacture

Also Published As

Publication number Publication date
JPH0720880B2 (ja) 1995-03-08
OA09037A (en) 1991-03-31
NO890565L (no) 1989-02-09
EP0317622A1 (de) 1989-05-31
RU2111010C1 (ru) 1998-05-20
CA1336407C (en) 1995-07-25
DK56389D0 (da) 1989-02-08
DE3854857D1 (de) 1996-02-15
NO175846B (de) 1994-09-12
EP0602761A1 (de) 1994-06-22
FI890603A0 (fi) 1989-02-08
AU612383B2 (en) 1991-07-11
FI95871B (fi) 1995-12-29
DK56389A (da) 1989-02-08
WO1988009670A1 (en) 1988-12-15
AU1962688A (en) 1989-01-04
NO890565D0 (no) 1989-02-09
EP0317622A4 (de) 1990-05-14
UA27716C2 (uk) 2000-10-16
FI890603L (fi) 1989-02-08
DE3854857T2 (de) 1996-08-22
JPH02500440A (ja) 1990-02-15
ATE132374T1 (de) 1996-01-15
EP0685236A1 (de) 1995-12-06
FI95871C (fi) 1996-04-10
NO175846C (no) 1994-12-21
EP0317622B1 (de) 1996-01-03

Similar Documents

Publication Publication Date Title
ATE331026T1 (de) Antigen-markierte nicht-infektiöse retrovirus- ähnlige partikel
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
HUP9801560A1 (hu) Szaponint és szterint tartalmazó vakcinák
WO2002020554A3 (en) Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines
EP0330359A3 (de) Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion
PT1159298E (pt) Péptidos de hiv, antigénios, composições de vacinas, kit de imunoensaio e um método de detecção de anticorpos induzidos por hiv
HUP9801242A1 (hu) Hepatitis B vakcina
IL86675A (en) Immunogen containing non- infectious hiv particles and pharmaceutical compositions containing the same
EP0306219A3 (de) HIV-Proteine und Peptide zur Verwendung in Diagnose, Prophylaxe und Therapie von AIDS
IT1254360B (it) Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
NZ221227A (en) Hiv envelope proteins, antigenic fragments vaccines; and diagnostic methods
ATE283066T1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
DK0910405T3 (da) Vaccine, som indeholder caprint arthritis-encephalitis-virus, og anvendelse til immunbeskyttelse imod HIV-1-infektion
EP1073461A4 (de) Virale chimären aus caev und hiv-1 genetischen elementen
EP0309898A3 (de) Methode zur Induktion einer zytotoxischen T-Zell-Antwort
EP0320034A3 (de) Synthetische Peptide, die immunologische Aktivität zeigen, benutzbar, um eine Impfung gegen Malaria vorzubereiten
ATE318300T1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
AU6791290A (en) Antigens relating to envelope glyoprotein of the virus of aids, particularly precursors of this glycoprotein, methods of obtaining these antigens and means employed in these methods, applications of these antigens in the preparation of immunogenic compositions or for the diagnosis of aids or
Osterhaus et al. Toward vaccination against feline leukemia virus and feline immunodeficiency virus infections
Zourbas et al. Immunization of dental surgeons against hepatitis B virus infection.
ZA9010116B (en) Process for the intensive in vitro culture of strains of babesia divergens,process for preparing exoantigens and vaccine containing these antigens

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees